Efficacy and Safety of Liraglutide Versus Sitagliptin, Both in Combination With Metformin, in Chinese Patients With Type 2 Diabetes: A 26-Week, Open-Label, Randomized, Active Comparator Clinical Trial

Diabetes, Obesity and Metabolism - United Kingdom
doi 10.1111/dom.12674
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Efficacy and Safety of Repaglinide Added to Sitagliptin in Japanese Patients With Type 2 Diabetes: A Randomized 24-Week Open-Label Clinical Trial

Endocrine Journal
EndocrinologyMetabolismDiabetes
2016English

Efficacy and Safety Over 26 Weeks of an Oral Treatment Strategy Including Sitagliptin Compared With an Injectable Treatment Strategy With Liraglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomised Clinical Trial

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients With Type 2 Diabetes: The EDIT Randomized Trial

PLoS ONE
Multidisciplinary
2015English

Efficacy and Safety of Dulaglutide Monotherapy Versus Metformin in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-3)

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

A 26-Week, Randomized Trial of Insulin Detemir Versus NPH Insulin in Children and Adolescents With Type 2 Diabetes (iDEAt2)

European Journal of Pediatrics
Child HealthPediatricsPerinatology
2018English

A Retrospective Comparison Study Between the Effectiveness and Safety of Fixed Dose Combination of Vildagliptin Versus Sitagliptin With Metformin in Type 2 Diabetes Mellitus Patients

Indian Journal of Pharmacy Practice
2018English

Safety and Efficacy From an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents With Schizophrenia

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2015English

A Randomized Clinical Trial of the Efficacy and Safety of Sitagliptin Compared With Dapagliflozin in Patients With Type 2 Diabetes Mellitus and Mild Renal Insufficiency: The CompoSIT-R Study

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy